SAN DIEGO, Jan. 11, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs' registration statement issued in connection with BioAge Labs' initial public offering ("IPO") held on September 26, 2024, have until March 10, 2025 to seek appointment as lead plaintiff of the BioAge Labs class action lawsuit.  Captioned Soto v. BioAge Labs, Inc., No. 25-cv-00196 (N.D. Cal.), the BioAge Labs class ...

With a focus on REITs, ETFs, Preferreds, and 'Dividend Champions' across asset classes, members gain complete access to our research and our suite of trackers and portfolios targeting premium dividend yields up to 10%.iREIT®+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income, diversification, and inflation hedging. Get started with a Free Two-Week Trial and take a look at ou ...

公司表现 - Advanced Micro Devices (AMD) 股价在2025年1月9日盘后交易中下跌4.76% [1] 行业竞争 - AMD 被认为在与 Nvidia 的竞争中处于不利地位 [1] 市场动态 - 视频发布于2025年1月9日 讨论了AMD的最新动态 [1]

Whether Lockheed Martin stock is a buy depends in large part on sales of its F-35.Lockheed Martin's (LMT -0.17%) F-35 Lightning II stealth fighter jet is the gift that keeps on giving. Estimated to be worth $1 trillion in total lifetime value, the F-35 warplane remains easily Lockheed's most important product. And this was demonstrated once again just late last year, when the week before Christmas saw the Pentagon deliver three gifts to Lockheed Martin worth $15.5 billion in total.Two gifts for Lockheed Mar ...

Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment at Caltech.-First employee and co-founder of 1200 Pharma as it spun out of Caltech garnering major investment (into the 8 figures).-Remains an avid investor, focused on market trends and especially biotechnology stocks.Analyst’s Disclosure: I/w ...

Immunic Inc (NASDAQ:IMUX) chief operating officer Jason Tardio joined Proactive to discuss the company’s progress in advancing its novel therapy vidofludimus calcium. He discussed the significant milestones achieved in 2024, such as the positive interim analysis of the ENSURE trials in relapsing multiple sclerosis (MS) and the anticipation of the results from the CALLIPER progressive MS study in April 2025. Proactive: Hello, you're watching Proactive. I'm joined by Immunic chief operating officer Jason Tard ...

NEW YORK, Jan. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Transocean Ltd. (NYSE: RIG) between October 31, 2023 and September 2, 2024, both dates inclusive (the “Class Period”), of the important February 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Transocean securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

公司股价表现 - AMD股价在2025年初表现不佳 最新交易日下跌4.76% 收于116.04美元 年初至今累计下跌超过5% [1] - AMD股价在过去一年下跌超过20% 创下14个月新低 被形容为"断崖式下跌" [2] 行业竞争格局 - AMD在AI芯片市场未能抓住机遇 而竞争对手Nvidia凭借突破性产品发布占据优势 [4] - Nvidia在芯片领域占据主导地位 其生态系统更受开发者青睐 [6] - AMD的AI芯片Instinct MI325X需求疲软 预计2025-2026年才能推出领先的AI服务器 而Nvidia下一代Blackwell芯片已售罄 [6] 分析师观点 - 高盛将AMD评级从"买入"下调至"中性" 目标价从175美元下调至129美元 分析师担忧AMD的竞争地位 [5] - 汇丰将AMD评级从"买入"下调至"减持" 目标价从200美元下调至110美元 认为AMD在AI GPU市场的路线图缺乏竞争力 [5] 技术分析 - 技术分析师指出AMD股价处于下降通道 连续三根看跌蜡烛图暗示短期内可能进一步下跌 [8] - 关键支撑位在100美元和90美元 阻力位在122美元和132美元 建议等待底部形成 [10] 投资机会 - 当前低股价可能代表战略性买入机会 特别是对于长期投资者 [7] - 部分分析师认为AMD可能在2025年超越Nvidia 但复苏取决于其在AI市场的创新和竞争能力 [7] - AI领域的潜在增长机会和关键技术支撑位可能为AMD带来投资价值 [11]

The U.S. saw inflation cool in 2024, but economists warn that President-elect Donald Trump's plan for the mass deportation of undocumented immigrants could greatly affect prices."Certainly the economic impacts are going to be felt," said David J. Bier, the director of immigration studies at the Cato Institute. "There's going to be supply chain issues. There's going to be increases in prices, decreases in services."Experts are concerned that deporting such a large number of undocumented immigrants at once co ...

Jason Hall has positions in Brookfield Renewable Partners. Tyler Crowe has no position in any of the stocks mentioned. The Motley Fool recommends Brookfield Renewable and Brookfield Renewable Partners. The Motley Fool has a disclosure policy. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley ...